POY_1170x120_8-12-19

Hemlibra

Soleo Health selected by Genentech to provide two limited distribution drugs

Soleo Health selected by Genentech to provide two limited distribution drugs

McKINNEY, Texas — Soleo Health, an innovative leader in specialty infusion services, announced the company has been selected by Genentech (member of the Roche Group), a world-leading biotechnology company with multiple products on the market and a strong development pipeline, to dispense two limited distribution drugs, Hemlibra and Ocrevus. Hemlibra (emicizumab-kxwh), for patients with hemophilia A with factor VIII inhibitors, received approval from

AllianceRx Walgreens Prime and Walgreens gain access to more specialty drugs

AllianceRx Walgreens Prime and Walgreens gain access to more specialty drugs

ORLANDO, Fla. and DEERFIELD, Ill.—AllianceRx Walgreens Prime, the combined central specialty and home delivery pharmacy formed by Walgreens and pharmacy benefit manager Prime Therapeutics LLC (Prime), and Walgreens, announce the availability of several new limited distribution drugs for its specialty patients. The new drugs treat rare conditions such as Huntington’s disease, severe asthma and cystic